T Cells in Cancer I

Moderator(s)

• 

  Yongxia Wu, MD, PhD (she/her/hers)

  Assistant Professor
  Medical College of Wisconsin, Wisconsin, United States

Presentations:

• 2:45 PM - 3:00 PM US ET

  Glucocorticoid signaling shapes the differentiation of tumor-infiltrating CD8+ T cells through TXNIP-dependent metabolic rewiring
  

  Author: Dandan Yang, PhD (she/her/hers) – Brigham and Women's Hospital, Harvard Medical School
• 3:00 PM - 3:15 PM US ET

  CD4+ T cell-mediated Immune Surveillance during Intestinal Tumor Initiation
  

  Author: Kelly McGovern (she/her/hers) – Harvard Univ.
• 3:15 PM - 3:30 PM US ET

  DUSP4 regulates anti-tumor CD8+ T cell response in colorectal cancer
  

  Author: Yongliang Zhang, PhD (he/him/his) – Yong Loo Lin School of Medicine, NUS
• 3:30 PM - 3:45 PM US ET

  Spatial colocalization of neoantigen-expressing tumor cells and cognate T cells in cancer
  

  Author: Adi Nagler, PhD (she/her/hers) – Dana-Farber/Harvard Cancer Center
• 3:45 PM - 4:00 PM US ET

  TCR-Associated Rasal1 rewires T-cell mitochondrial metabolism to regulate checkpoint immunotherapy
  

  Author: Nikhil Ponnoor Anto, PhD (he/him/his) – Univ. de Montreal